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As we move towards the next millennium, providing high quality
care to all patients with cancer has become a key objective for both
clinicians and politicians. How to achieve this remains the subject
of intense debate, particularly on issues related to specialization
and centralization. Extensive reviews of cancer specialization-
related studies by Stiller (1994) and Selby et al (1996) demon-
strated wide variations in outcome for many common cancers but
concluded that the evidence supported a case for more specialized
care. Against this background, the Chief Medical Officer assem-
bled a working party (The Expert Advisory Group on Cancer) to
evaluate cancer services in England and Wales leading to the publi-
cation of the Calman–Hine Report (1995). A central premise of the
report was that such variations in cancer care were unacceptable
and recommended that all patients with cancer should have access
to a uniformly high quality of care wherever treated. The report
separated cancers into three categories – common (e.g. colorectal,
lung, breast), moderately common (e.g. gastro-oesophageal,
ovarian, pancreatic) and uncommon (e.g. paediatric, testicular) – to
serve as an initial framework by which to consider the provision of
specialized cancer services. The beneficial role of specialization for
less common cancers, such as childhood malignancies, was well
established (Steller and Bunch, 1990), and a network of centres
providing paediatric oncology already existed. For the commoner
malignancies, affecting larger patient numbers with varying presen-
tations, it was envisaged that cancer care be delivered through an
integrated network of cancer units (mainly based in district general
hospitals) and cancer centres (hospitals offering dedicated
oncology, radiotherapy and specialized surgical services), in close
collaboration with primary and palliative care groups.
The paper by Stockton and Davies in this issue stands at the
crossroad of cancer specialization in the UK. It is a comparative
study of outcome for six different cancers between patients treated
at hospitals with radiotherapy and oncology services (Group 1)
versus district general hospitals (Group 2). Although the study
period spanned from 1989 to 1993, and hence predated the
Calman–Hine era, the Group I and II hospitals are broadly equiva-
lent to cancer centres and cancer units respectively. Hence, this
study provides a baseline against which future audits may be judged.
The principal finding, that adjusted survival was significantly better
in Group 1 hospitals, supports the aforementioned evidence in
favour of cancer specialization and, on the face of it, would appear
to support the Calman–Hine philosophy. The factors giving advan-
tage to the cancer hospitals are unclear but that of stage migration is
perhaps understated. Referred to as the ‘Will Rogers’ phenomenon,
shifts in tumour stage (mainly upstage) as a consequence of
improved diagnostic technology (e.g. radiology and pathology) are a
major source of misleading survival statistics in cancer (Feinstein et
al, 1985). In common with others, the study also found that special-
ized care was most beneficial in certain cancers, namely breast,
ovarian and rectal tumours. While the explanation for this is as yet
unclear, it appears that these cancers are particularly sensitive to
suboptimal management, and hence there is a distinct need to prior-
itize resources and training in these areas.
An alternative pessimistic interpretation of Stockton and
Davies’ study is that it raises doubts about the potential delivery of
an equally high-quality care across both cancer centres and cancer
units. This undermines the Calman–Hine principles and poten-
tially introduces negative competitiveness between centres and
units. Such judgement seems unjust to those dedicated to the
delivery of specialized cancer services within a district hospital as
there is evidence suggesting that high quality care can be success-
fully established where specific commitments are made. For
district hospitals participating in multi-centred trials, results are
comparable with specialist centres, though adherence to protocols
off trials may be poor (Sengupta et al, 1999). A study from
Manchester (Kingston et al, 1992), has shown that specialist
colorectal cancer surgeons in district hospitals can produce similar
results to their colleagues in teaching hospitals, and for rectal
cancer, there is well-documented evidence (albeit non-compara-
tive) that outcome from surgical treatment in the hands of an
enthusiast is comparable to best trial results (Heald and Ryall,
1986). With surgery playing a pivotal role in the initial manage-
ment of many such cancers, the emphasis must be on the quality
and training of surgeons treating these patients (Chan, 1999;
Renehan and O’Dwyer, 1999). Numerically, the majority of
common cancers will continue to be treated in the cancer units
where existing cancer specialization must be nurtured and
expanded.
It seems likely that the findings of Stockton and Davies are
reproducible throughout the UK, reflecting an imbalance between
cancer centres and cancer units. The recommendations of
Calman–Hine were designed to operate within the existing system
of district, teaching and cancer hospitals in the UK, but unfortu-
nately, the envisaged ‘integrated network’ has failed to materi-
alize. Achieving the targets of Saving Lives: Our Healthier Nation
(1999) to improve cancer survival over the next decade, is not
simply about injecting manpower and finances, but about the
development, nurturing and sustainment of mutually supportive
and appropriately trained specialist teams. Only when clinicians,
purchasing groups and ministers cooperate, will cancer survival in
the UK mirror that of other developed nations.
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